- Home
- HMY vs TECH Comparison
HMY vs TECH Comparison
Compare HMY & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HMY | TECH |
|---|---|---|
| Founded | 1950 | 1976 |
| Country | South Africa | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 9.2B |
| IPO Year | N/A | 1989 |
Fundamental Metrics
Financial Performance| Metric | HMY | TECH |
|---|---|---|
| Price | $21.72 | $59.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 14 |
| Target Price | $16.00 | ★ $71.23 |
| AVG Volume (30 Days) | ★ 3.8M | 1.6M |
| Earning Date | 01-01-0001 | 02-04-2026 |
| Dividend Yield | ★ 0.77% | 0.54% |
| EPS Growth | ★ 67.74 | N/A |
| EPS | ★ 1.29 | 0.49 |
| Revenue | ★ $4,161,584,110.00 | $1,216,732,000.00 |
| Revenue This Year | $40.10 | $2.33 |
| Revenue Next Year | $14.83 | $7.05 |
| P/E Ratio | ★ $16.74 | $121.67 |
| Revenue Growth | ★ 20.39 | 3.85 |
| 52 Week Low | $7.97 | $46.01 |
| 52 Week High | $22.25 | $79.28 |
Technical Indicators
Market Signals| Indicator | HMY | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 67.32 | 46.70 |
| Support Level | $21.22 | $56.84 |
| Resistance Level | $21.96 | $59.58 |
| Average True Range (ATR) | 0.78 | 1.72 |
| MACD | 0.12 | -0.07 |
| Stochastic Oscillator | 92.89 | 48.24 |
Price Performance
Historical ComparisonAbout HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.